Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
JLJennifer L. GuerrieroASAlaba SotayoHPHolly PonichteraJAJessica A. CastrillonALAlexandra L. Pourzia
Dana-Farber Cancer Institute · Brigham and Women's Hospital · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
546
total citations
- FWCI
- 21.86
- Percentile
- 100%
- References
- 36
Citations per year
Authors
14Topics & keywords
Topics
Keywords
- Histone deacetylase
- Histone deacetylase inhibitor
- Cancer research
- Macrophage
- Immune system
- Biology
- Immunotherapy
- Acquired immune system
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.